Lassa virus, the causative agent of Lassa fever, causes thousands of deaths annually and is a biological threat agent, for which there is no vaccine and limited therapy. The nucleoprotein (NP) of Lassa virus has essential roles in viral RNA synthesis and immune suppression, the molecular mechanisms of which are poorly understood. Here we report the crystal structure of Lassa virus NP at 1.80 Å resolution, which reveals amino (N)-and carboxy (C)-terminal domains with structures unlike any of the reported viral NPs. The N domain folds into a novel structure with a deep cavity for binding the m7GpppN cap structure that is required for viral RNA transcription, whereas the C domain contains 39-59 exoribonuclease activity involved in suppressing interferon induction. To our knowledge this is the first X-ray crystal structure solved for an arenaviral NP, which reveals its unexpected functions and indicates unique mechanisms in cap binding and immune evasion. These findings provide great potential for vaccine and drug development.
Several arenaviruses, including Lassa virus (LASV), can cause severe viral haemorrhagic fevers in humans with high morbidity and mortality, to which there is no vaccine and limited treatment [1] [2] [3] [4] . These pathogenic arenaviruses are public health threats and potential biological threat agents. LASV, like other arenaviruses, is a single-stranded ambisense RNA virus with two genomic RNA segments encoding four genes 1 . The NP encapsidates viral genomic RNAs into ribonucleoprotein (RNP) complexes and is required for both RNA replication and transcription [5] [6] [7] . Like bunyaviruses and orthomyxoviruses, arenaviruses snatch the cap structure of cellular mRNAs to use as primers to initiate viral transcription, the exact mechanism of which is unknown. The capsnatching mechanism of arenaviruses seems to be unique, as evidenced by the cytoplasmic localization and the much shorter 59 non-templated mRNA sequences [8] [9] [10] [11] . Severe arenavirus infections including lethal Lassa cases are associated with a generalized immune suppression in the infected hosts [12] [13] [14] [15] [16] [17] [18] , the exact mechanism of which is unclear but is thought to involve NP's ability to suppress the induction of type I interferon (IFN) 19, 20 . To address the functional mechanisms of NP in viral RNA synthesis and host immune suppression, we set out to determine the crystal structure for LASV NP, knowledge derived from which can be extended to other arenavirus NP proteins, as all known arenaviral NP proteins share high sequence identity ( Supplementary Fig. 1 ).
Structure determination
The full-length 569-residue LASV NP protein (Josiah strain) was expressed and purified as a recombinant MBP fusion protein in Escherichia coli as described in Methods. The purified protein exists mainly in two forms, with a majority in trimeric and some in hexameric form. Both forms bind random RNAs, which are longer and more abundant in the hexamers than in the trimers, a feature that is similar to known NPs from negative-strand RNA viruses [21] [22] [23] [24] . We attempted to crystallize both forms, but only the trimeric NP formed crystals. The crystals showed heavy twining with a twin fraction of ,0.43 and the reflection intensity statistic jE 2 -1j 0.681/0.681. Initial phases were obtained in a space group of P321 using the multiple wavelength anomalous diffraction (MAD) with Samarium derivative. The true space group was P3 with three subunits in an asymmetric unit. The structure was refined to a resolution of 1.80 Å with de-twining. The crystal structures do not contain RNA, indicating that only RNA-free NP was able to form crystals. The final structural model of the native LASV NP has an R factor of 0.18 and an R free of 0.20. Data collection, phasing and refinement statistics are provided in Supplementary Table 1 .
Overall structure of LASV NP protein
In the NP protomer structure, 514 residues of the 569-residue LASV NP protein were built into the model (Fig. 1a ). The electron densities for residues 1-6, 147-157, 339-363, 518-521, 562-569 were not well defined. LASV NP protomer, like other viral NPs 7-10 , is composed of the N-and the C-terminal domains, but neither domain shows structural similarity to any known viral NPs (Supplementary Table 2 ). The large N domain (residues 7-338) consists mainly of a-helices and coils, whereas the C domain (residues 364-561) forms a typical a/b/a sandwich architecture (Supplementary Text 1). In the trimeric form, three subunits lie in a head-to-tail orientation to form a ringshaped structure with a three-fold symmetry ( Fig. 1b and Supplementary Fig. 2 ). Surface rendering reveals a deep cavity located near the bottom of the N domain and a large cavity at the top of the C domain ( Fig. 1c, d) , which are the cap-binding site and the 39-59 exoribonuclease active site (see below), respectively. The interface area between the subunits is 455 Å 2 , representing 1.9% of total surface area of a subunit (23,343 Å 2 ). The central hole of the trimeric structure is 23 Å in diameter, whereas the head ring is 98 Å and the body ring is 118 Å ( Supplementary Fig. 2 ).
LASV NP is a 39-59 exoribonuclease
A Dali search (http://ekhidna.biocenter.helsinki.fi/dali_server) identified several structures similar to the C domain of NP, including several known 39-59 exonucleases/exoribonucleases in bacteria and humans (for example, human TREX1) (Supplementary Text 2), all of which belong to the DEDDH subfamily of the DEDD (DnaQ) superfamily [25] [26] [27] . The human TREX1 structure shows two Mn 21 cations in the active site 27 . We identified one Mn 21 in each subunit of LASV NP by crystal fluorescent scanning, but could not identify the second Mn 21 , possibly because it was not well ordered in the absence of the RNA substrate. The C domain of NP superimposes well with the portion of TREX1 that coordinates the Mn 21 cations ( Fig. 2a ), in particular the b5, b6, b7, b8 and b9 strands of NP completely overlap with the central b-sheets of TREX1. The putative exonuclease catalytic residues D389, E391, D466, D533 and H528 are absolutely conserved in all known arenavirus NP proteins and are located at identical positions as in the TREX1 active cavity ( Fig. 2b) . Taken together, the structural evidence indicates that LASV NP is a new member of the DEDD 39-59 exonuclease superfamily.
We conducted in vitro assays to characterize the 39-59 exonuclease activity of the wild-type LASV NP, as well as NP mutants at putative catalytic sites. We showed that the wild-type protein, in its trimeric or hexameric form, could digest both DNA and RNA substrates (Supplementary Figs 3 and 4). As divalent cations are essential for exonuclease activity 25 , we determined what divalent cation was most effective for NP exonuclease to digest various single-stranded RNA (ssRNA) species that are based on the NP gene in the viral genomic sense (60 nucleotides, vRNA), complementary antigenomic sense (30 nucleotides, cRNA), or in capped mRNA form (126 nucleotides, mRNA) (Methods). We showed the order of efficiency as Mn 21 .Co 21 . Mg 21 . Ca 21 .Zn 21 .Fe 21 .Ni 21 .Cu 21 ( Supplementary Fig. 5 ). Wild-type NP could cleave various ssRNA species efficiently ( Fig. 2c ), regardless of whether they contained a hydroxyl (59OH) group, triphosphate (59ppp), or a cap at the 59 termini (Methods). In contrast, the NP catalytic mutants (D389A, E391A and D466A) showed markedly reduced RNase activity ( Fig. 2c and Supplementary Fig. 4 ). In addition, we showed that wild-type NP, but not its catalytic mutants, could digest cellular RNA substrates in vitro with a preference towards short RNA species over long ones (for example, 18s rRNA versus b-globin mRNA, the large versus small fragments in the RNA ladder) (Supplementary Figs 6 and 7). We also demonstrated that wild-type NP, but not its catalytic mutants (D389A, E391A and D466A), can efficiently degrade various dsRNA molecules with 59-hydroxyl (59OH), single 59-triphosphorylate (59ppp/59OH) and double 59-triphosphorylate (59ppp/59ppp), as well as the long dsRNA mimic poly(I:C) ( Fig. 2d and Supplementary Fig. 8 ).
Fluorescence scanning analysis identified a zinc ion in the NP structure, despite the fact that no typical zinc finger motif was predicted from the amino acid sequence and that no zinc compounds were used during the purification and crystallization processes. Although the residues C506, C529, H509 and E399 that coordinate the zinc ion are not of the typical zinc-binding motif 28 , they appear to adopt a zinc finger fold in structure 28, 29 . The CCHE zinc-binding site is located in the C domain near the 39-59 exonuclease active site (Supplementary Fig. 9 ). We speculate that zinc binding may be required to 
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stabilize the structure of the C domain and/or contribute to the substrate binding and specificity of the exonuclease activity 28, 29 . A highly positively charged groove located between the N and C domains is predicted as the genomic RNA-binding site ( Supplementary Fig. 10 ). An in vitro assay confirmed that RNAs are bound within the purified NP oligomers and protected from its intrinsic exonuclease activity ( Supplementary Figs 10 and 11 , Supplementary Text 3 and Methods).
Exonuclease and immune evasion
To determine whether the exoribonuclease activity is important for the transcriptional function of NP, we generated alanine substitution at five putative catalytic sites, D389A, E391A, D466A, D533A and H528A, in the mammalian cell expression vectors of either native or Myc-tagged NP gene, and examined the activity of each mutant in transcribing the LASV minigenome RNA that encodes a Renilla luciferase (RLuc) reporter gene 20 (Methods). As shown in Fig. 3a , each NP mutant expressed comparable protein levels to the wild type, and led to similar folds of increase in RLuc activity, indicating that these mutations did not alter the overall structure (Supplementary Text 4 and Supplementary Fig. 12 ) or affect the basic function of NP in mediating viral RNA transcription. We next examined whether the exoribonuclease activity is required for NP's function in the suppression of IFN 19, 20 . As expected, wildtype NP strongly inhibited Sendai-virus-induced IFN-b activation by a promoter assay (Methods), whereas all the catalytic mutants D389A, E391A, D466A, D533A and H528A showed a complete loss of function at a low level of transfected expression vectors (10 ng) and showed various levels of deficiency at higher levels ( Fig. 3b and Supplementary Fig. 13 ). Our results confirm a previous study showing that the D389 residue of LASV NP, as well as its corresponding residue D382 in the prototypic arenavirus lymphocytic choriomeningitis virus (LCMV), is required for IFN suppression but not for viral RNA transcription 30 , and may help to explain the loss of IFN suppression for Tacaribe virus NP ( Supplementary Fig. 14 and Supplementary Text 5). In summary, these data provide strong genetic evidence for an important role of the NP exoribonuclease activity in suppressing the IFN induction.
Viral infections are usually detected by the cellular pattern-recognition receptors (PRRs) such as toll-like receptors (TLRs) and cytosolic RNA sensors, retinoid-acid-inducible gene-I-like helicase (RIG-I) and melanoma differentiation-associated protein 5 (MDA5), which recognize the pathogen-associated molecular patterns (PAMP) RNA ligands and initiate signalling pathways to induce the production of type I IFNs 31, 32 . We hypothesize that NP prevents the virus-induced IFN induction by degrading the PAMP RNA ligands that otherwise would trigger the viral sensors in the cells.
We examined whether the NP RNase function is essential for suppressing the IFN production induced by the immunostimulatory RNAs, that is, poly(I:C) and the virion RNAs extracted from Pichinde virus, which is a prototypic arenavirus 33 . We found that whereas wild-type NP efficiently inhibited the IFN-b activation induced by poly(I:C) or by Pichinde-virion-associated RNAs, none of the five catalytic mutants (D389A, E391A, D466A, D533A and H528A) exhibited any suppressive activity (Fig. 3c ). Similar results had been reported for LCMV NP 34 .
We have shown that the NP exoribonuclease activity is essential for suppressing both viral-infection-induced and immunostimulatory-RNA-induced IFN production. A good example of exonucleasemeditated suppression of IFN production has been demonstrated for human TREX1 protein, which degrades small ssDNAs and dsDNAs accumulated during cellular apoptosis. Failure to clear these DNA fragments by TREX1 natural mutants leads to the activation of cellular DNA receptors to trigger a persistent production of IFNs that contributes to human autoimmune diseases 27, [35] [36] [37] [38] . How does the NP RNase activity function in suppressing the virus-induced IFN production? A simplistic but reasonable model is that the NP RNase activity is able to remove viral PAMP RNAs that are otherwise recognized by the cellular PRRs. Although we have shown that LASV NP protein can degrade various RNA templates in vitro, we believe that the NP RNase activity must be highly regulated in vivo, as NP does not cause a generalized nonspecific RNA degradation process of cellular or viral RNAs in the cells (Supplementary Text 6 and Supplementary Fig. 15 ). We propose that the NP RNase activity in the cells is restricted to viral PAMP RNAs through a yet-to-be characterized regulatory mechanism. A recent publication has shown a direct protein-protein interaction of NP with RIG-I and MDA5 (ref. 34 ), which may be one possible mechanism for the specific nuclease activity of NP against these PRR-associated PAMP RNAs.
LASV NP is a cap-binding protein
The N domain adopts a completely novel fold not found in the Dali server. To identify the cap-binding residues in the deep cavity of the N domain, we attempted to soak and perform co-crystallization of LASV NP with m7GpppG, triphosphorylated, diphosphorylated or monophosphorylated ribonucleotides (Methods). We could observe the clear density for the triphosphate and partial density for uridine ( Supplementary Fig. 16 ) from the triphosphorylated ribonucleotide complex structures. We also visualized the structure of NP in complex with dTTP with a clear original F o 2F c electron density contoured at 2.5s for dTTP (Fig. 4a ). The triphosphate group of dTTP was bound in the middle of the cavity in an identical manner as that of UTP ( Supplementary Fig. 16 ), in which it was anchored by salt bonds formed with the side chains of the conserved residues K309, R300, R323 and K253. In the deep end of the cavity, thymidine occupied a hydrophobic pocket that is composed of residues F176, W164, L172, 
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M54, L120, L239 and I241. We propose that this dTTP-binding pocket is the binding site for the cap structure m7GTP and that the residues located within the pocket may have to change conformation to accommodate the cap moiety. Although the N domain of NP is not structurally similar to any of the cap-binding proteins (Supplementary Table 3 ), its hydrophobic thymidine-binding pocket shares common features for cap binding 39, 40 . Moreover, the NP cap-binding cavity has a unique feature in that its entrance contains another hydrophobic region that is composed of the hydrophobic residues Y319, Y209, Y213, L265 and the acidic residue E266, which can potentially act as the binding site for the second base of the m7GpppN (where N represents G, C, U or A) cap structure. The entrance of the cap-binding cavity has an oval shape with a diameter of 9-13 Å , which is a perfect fit for the single-stranded mRNA. We propose that a loop composed of residues K236 to S242 serves as a 'gate' for the capped template (primer) binding and that the entire structure of m7GpppN, including the cap m7G, the triphosphate, and at least one more nucleotide, is embedded within the deep cavity. This binding feature is unlike other known cap-binding proteins, in which only the m7G caps are locked in between the sandwich, whereas the rest of the RNA molecule is exposed 39, 40 .
To characterize the role of the cap-binding residues in viral RNA transcription, we examined a panel of NP mutants with alanine substitution of residues located inside and at the entrance of the cavity and that are conserved among all known arenaviruses for their ability to mediate the cap-dependent viral RNA transcription using the LASV minigenome replicon assay (Methods). Wild-type NP (with or without Myc tag) produced up to a 1,000-fold increase in RLuc reporter activity over a control reaction, and more than 100-fold increase even when expressed at a low level (15 ng of transfected NP plasmid DNAs). All mutant proteins were expressed at similar levels as the wild type transfected with 15-30 ng of plasmid (Fig. 4b) .
Compared to the wild type, the K253A and E266A mutants completely lost the RNA transcription activity, and the Y319A, F176A, W164A, K309A and R323A mutants showed significantly decreased activity (Fig. 4c ). R300A had a minor effect, whereas W12A and Y209A had no effect. It is worth noting that none of these mutants was found to impact the NP function in the suppression of IFN (Supplementary Fig. 17 ). These functional data correlate well with the proposed cap-binding function of some of these conserved residues.
The unique cap-binding feature of LASV NP, in that the entire cap structure m7GpppN is buried within the cavity, has significant implications in understanding the distinctive cap-snatching mechanism of arenaviruses. Once NP binds and protects the 59 cap m7GpppN, the rest of the mRNA molecule located outside of the cavity may be susceptible to viral and/or host exonuclease-mediated degradation and/or to endonuclease-mediated cleavage ( Supplementary Fig. 9 ). This may help to explain the relatively short (1-4 nucleotides) 59 non-templated sequences in arenavirus mRNAs 1, 8, 9 . However, individual mutation of the NP exonuclease catalytic sites did not show any defect in viral cap-dependent RNA transcription (Fig. 3a) , indicating that the NP exonuclease activity is not essential (required) for generating the capped primers. It is worth noting that we did not identify an influenza polymerase PA-like endonuclease structural motif 41, 42 within LASV NP structure ( Supplementary Table 4 ). Instead, recent studies indicated that the LASV L polymerase protein contains an endonuclease domain in its N terminus that is crucial for the cap-dependent viral RNA transcription 43, 44 .
Conclusion
Our structural analysis and functional assays have demonstrated that the C domain of LASV NP contains 39-59 exoribonuclease activity that is required for suppressing IFN-b induction. We have provided evidence to suggest that the NP RNase activity is highly regulated in cells and proposed a novel mechanism by which the NP RNase activity may specifically remove the viral PAMP RNA ligands to suppress the production of IFN. Another important feature of LASV NP protein is that its N domain contains a deep cavity to bind and shield the entire m7GpppN cap structure, which is distinct from other known capbinding proteins, and has shed light on the unique cap-snatching mechanism of arenaviruses. In addition, we have also identified an unusual zinc-binding site and the viral RNA-binding groove in the LASV NP structure. Taken together, these findings reveal several new and potentially vulnerable targets on NP for the development of antivirals and effective vaccines to combat LASV and other pathogenic arenaviruses that can cause severe haemorrhagic fever diseases in humans.
METHODS SUMMARY
The crystals were grown using the sitting-drop technique, and the native structure was determined with the MAD data. All the NP mutations were generated using the QuikChange site-directed mutagenesis kit (Stratagene) and confirmed by DNA sequencing. The RNA synthesis assays used the LASV minigenome (MG) system, and the Sendai-virus-induced IFN-b activation assay was conducted as described 45 map for the dTTP in blue contoured at 2.5s. The F176 and W164 or L172 (L120) residues form a typical cap-binding sandwich structure. The middle cavity binds the triphosphate moiety and the hydrophobic cavity entrance can accommodate the second base of the cap structure. The carbon atoms are in pink for the dTTP, in yellow for the deep cavity residues and in green for the cavity entrance residues. b, The NP mutants were expressed at similar levels as the wild type at 15-30 ng plasmid (WT-15, WT-30) in the transfected mammalian cells. c, Mutational analyses of the residues within the cap-binding cavity for the transcriptional activity using the LASV minigenome assay.
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conducted by transfecting HEK293 cells with the IFN-b-LUC promoter construct and either wild-type or mutant NP construct, followed by Lipofectamine-2000mediated transfection of poly(I:C) or Pichinde-virion-isolated RNAs. Activation of the IFN-b promoter was quantified by measuring the LUC activity.
METHODS
Protein expression and purification. The full-length LASV NP gene (Josiah strain) was cloned into the pMAL-c2X-derived pLou3 plasmid, downstream of the TEV cleavage site following the MBP gene. This construct, encoding the N-terminal MBP tagged NP protein, was transformed into Rosetta cells (Novagen). After IPTG induction at a final concentration of 0.03 mM overnight at 20 uC, the cells were harvested by centrifugation at 8,000 r.p.m. for 20 min and suspended in TEN buffer (20 mM Tris, pH 7.5; 0.2 M NaCl, 10% glycerol, 1 mM EDTA) with protease inhibitors (Roche), 1 mM DNase (Sigma) and 1 mM phenylmethylsulphonyl fluoride (Sigma). After cells were lysed by a cell disruptor (Constant System Ltd), the cell lysates were collected by centrifugation at 20,000 r.p.m. for 30 min and applied on an amylose column. The column was washed with .10-column volumes of the sample buffer. The MBP-NP fusion protein was eluted with the TEN buffer containing 10 mM maltose. The MBP-NP fusion protein was then cleaved by Tev proteinase. The MBP portion was removed through two amylose columns, and the NP protein was purified to homogeneity by gel filtration column. Trypsin digestion coupled with mass spectroscopy confirmed that the purified LASV NP protein was homogenous (data not shown), with a final concentration of 7 mg ml 21 . Crystallization and data collection. A Cartesian robot (Genomic solutions) was used to screen for optimal crystallization conditions. The native crystals were obtained in 0.2 M LiCl 2 and 20% PEG3350 in 1 week at 20 uC. To obtain the NP complex with m7GpppG, m7GTP, or m7GDP, the NP protein was incubated with individual compound at a concentration of 2 mM for 30 min on ice and the crystallization conditions were screened. The NP complex with other triphosphorylated, diphosphorylated or monophosphorylated nucleotides were formed by incubating the NP protein with 50 mM of the respective compounds for 30 min on ice and the crystallization conditions were screened. The crystallization conditions were optimized until the resolution of the data was better than 2.5 Å . All crystals grew in 0.2 M KCI or 0.2 M LiCl and 14-22% PEG3350. The NP complexed with manganese ion was obtained by crystallizing the NP protein in 0.2 M MnCl 2 , 25% PEG3350 followed by soaking the crystals in 0.2 M NaCl 2 , 20% PEG3350 and 15% glycerol three times for 15 min each. The presence of the manganese and the zinc ions was confirmed in all the crystals by fluorescence scanning at the Diamond light sources UK. All the crystals were protected by cryoprotectants that contain 15% to 20% glycerol in the crystallization conditions before data collection in IO2 or IO3 at the Diamond light sources UK. The Samarium derivative crystals were obtained by soaking the crystals overnight in 100 mM Samarium acetate, 0.2 M LiCl and 16% PEG3350, and was protected in a cryoprotectant of 0.2 M LiCl, 16% PEG3350 and 20% glycerol. The Samarium derivative MAD data were collected at a wavelength of 1.83 Å for peak data, 1.84 Å for inflection data and 1.45 Å for remote data from a single crystal. All the data were indexed, integrated and scaled by HKL2000 or Mosflm and Scale. Structure determination. The crystals were heavily twined with a twining fraction of 0.43. The initial phases were obtained from a space group of P321 using the MAD data and SOLVE 46 . The initial model was built using RESOLVE 46 , Buccaneer and Coot 47 . It was found that the true space group of the crystals was P3 during the structure refinement. The structures were refined using REFMAC5 48 , and the water molecules were added into the structure by ARP/ wARP 49 . The F o 2 F c maps for ligands (dTTP, UTP, zinc and manganese) were calculated before any ligand was added into the structures. The structures were de-twinned at last using REFMAC5, and the structures were evaluated using Molprobity 50 . In vitro RNA synthesis. The 30-nucleotide cRNA (sense) sequence 59-CUGGGC UUACCUAUUCUCAGCUGAUGACCC-39 was derived from the LASV NP (Josiah strain) S segment (nucleotides 2186-2215 in antigenomic orientation) and chemically synthesized by Eurogentic. The 30-nucleotide vRNA (in genomic orientation) sequence 59-GGGUCAUCAGCUGAGAAUAGGUAAGCCCAG-39 was complementary to the cRNA. The cRNA (30 nucleotides) was used as one of the three substrates for 39-59 exoribonuclease assay. To obtain the blunted dsRNA, both cRNA and vRNA oligonucleotides were dissolved into 0.1 M NaCl, 1 mM EDTA and 0.1 M Tris pH 8.0 at the final concentration of 200 mM, and an equal amount of the two oligonucleotides was mixed together and annealed in a thermocycler as follows: 95 uC for 3 min, 68 uC for 1 min and then 4 uC.
The 59-triphosphorylated vRNA was generated by in vitro transcription of the partial dsDNA template formed by the T7 promoter sequence 59-AATTTAA TACGACTCACTATAGG-39 and the reverse complement of the T7 promoter sequence and of the LASV (Josiah strain) S segment (nucleotides 2186-2215) 59-CTGGGCTTACCTATTCTCAGCTGATGACCCTATAGTGAGTCGTATT AAATT-39 using the T7 MEGAshortscript kit following the manufacturer's instructions (Ambion). A similar strategy was use to generate the 32-nucleotide triphosphorylated cRNA with the T7 primer and LASV (Josiah strain) S segment (nucleotides 2186-2213) 59-GGGTCATCAGCTGAGAATAGGTAAGCCCA GCCTATAGTGAGTCGTATTAAATT-39. A similar strategy was used to generate
